Security key
71678J209
Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI)
CUSIP: 71678J209
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 99,607
- Total 13F value
- $170,571
- Share change
- -2,506
- SEC-reported price per share
- $1.73
- Number of holders
- 14
- Value change
- -$21,147
- Number of buys
- 2
- Number of sells
- 5
- Shares outstanding
- 25,296,136
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
14
Top holders
10
PTPI full security history
Ownership snapshot
Full 13F holder table
Petros Pharmaceuticals, Inc. SEC filings
Petros Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
John D. Shulman
Disclosed value leader
John D. Shulman
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5
13F
Highest disclosed value: $19,563,156
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
John D. Shulman has the largest disclosed position value at $19.56M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens John D. Shulman's linked filing trail.
Disclosed position value
Top 5
John D. Shulman
$19.56M
VANGUARD GROUP INC
$64.6K
Schonfeld Strategic Advisors LLC
$47.1K
RENAISSANCE TECHNOLOGIES LLC
$34K
BlackRock Finance, Inc.
$33.5K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| John D. Shulman |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$19,563,156
5,812,873 shares
mixed-class rows
|
— | 22 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$64,576
31,811 shares
|
— | 30 Jun 2023 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
—
denominator unverified
|
$47,096
23,200 shares
|
— | 30 Jun 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$34,000
16,779 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$33,515
16,510 shares
|
— | 30 Jun 2023 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
—
denominator unverified
|
$27,400
10,000 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
99,607
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
14
Q3 2023 holders
14
Holder diff
0
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|